{"id":"chlorfenethazine","rwe":[],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"elroquil","offLabel":[],"synonyms":["chlorfenethazine","chlorfenethazine hydrochloride","elroquil","marophen","chlorphenethazine","ethyl chlorpromazine","chlorfenethazine HCl"],"timeline":[],"approvals":[],"brandName":"Elroquil","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Think of Elroquil like a key that fits into a lock. The lock is a protein or receptor in the body, and when the key fits in, it can either turn the lock (activating the protein) or block it (inhibiting the protein). This can help to either increase or decrease the activity of certain cellular processes, depending on the specific protein involved.","oneSentence":"Elroquil works by binding to and modulating the activity of a specific protein or receptor, although the exact mechanism is unknown.","technicalDetail":"Elroquil's mechanism of action is likely to involve competitive binding to a specific protein or receptor, potentially altering its conformation and subsequent interactions with downstream effectors. However, without further information on its target and drug class, it is difficult to provide a more detailed explanation of its pharmacological effects."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/615","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=chlorfenethazine","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T09:33:16.092636","biosimilars":[],"competitors":[],"genericName":"chlorfenethazine","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"007719","UNII":"J205NZ30N2","CHEBI":"CHEBI:125651","RXNORM":"20785","UMLSCUI":"C0055355","PUBCHEM_CID":"62861","MESH_SUPPLEMENTAL_RECORD_UI":"C002815"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Elroquil, also known as chlorfenethazine, is a small molecule drug with unknown target and drug class. Its commercial status is unclear, and it is not known if it is FDA approved or off-patent. Elroquil is used to treat unknown indications, and its half-life, bioavailability, and generic manufacturers are also unknown. As a pharma professional, it is essential to conduct thorough research on this drug to understand its safety considerations and potential applications. Further investigation is required to determine its efficacy and potential side effects.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}